These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10157744)

  • 1. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
    Hakim Z; Pierson JF; Pathak DS
    Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744
    [No Abstract]   [Full Text] [Related]  

  • 2. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
    McGhan WF
    Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed drug-drug cost effectiveness methodology.
    Gagnon JP; Osterhaus JT
    Drug Intell Clin Pharm; 1987 Feb; 21(2):211-6. PubMed ID: 3103997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost benefit and cost effectiveness analysis: a bibliography for pharmacists.
    Lunik MC; Segal R
    Hosp Pharm; 1986 Nov; 21(11):1072-5. PubMed ID: 10311748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where does high-quality research in economic evaluation come from?
    Zhang JX
    Pharmacotherapy; 2009 Jan; 29(1):1-2. PubMed ID: 19113791
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation and justification of clinical pharmacy services.
    Anderson SV; Schumock GT
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec; 9(6):539-45. PubMed ID: 19941431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic principles and methods: including pharmacoeconomics into hospital pharmacy practice.
    Sanchez LA
    Hosp Pharm; 1994 Nov; 29(11):1035-6, 1039-40. PubMed ID: 10138578
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacoeconomic factors in the treatment of acute hypertension.
    Shulkin DJ
    Hosp Formul; 1994 Aug; 29 Suppl 2():S15-20. PubMed ID: 10135742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics.
    Bridges JF
    Appl Health Econ Health Policy; 2003; 2(4):213-24. PubMed ID: 15119540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forget CEA (cost effectiveness analysis). Use DEA (data envelopment analysis)!
    Rosenberg D
    J Health Hum Resour Adm; 1991; 14(1):109-12. PubMed ID: 10115636
    [No Abstract]   [Full Text] [Related]  

  • 12. Using pharmaceutical cost analyses for decision making.
    U'Ren NA
    Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832
    [No Abstract]   [Full Text] [Related]  

  • 13. Conducting pharmacoeconomic evaluations in a hospital setting.
    Sanchez LA
    Hosp Pharm; 1995 May; 30(5):412, 415-6, 428. PubMed ID: 10142378
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness analysis in health care.
    Chalfin DB
    Hosp Cost Manag Account; 1995 Jul; 7(4):1-8. PubMed ID: 10143321
    [No Abstract]   [Full Text] [Related]  

  • 15. Measuring cost effectiveness of cardiac care.
    Virzi L
    J Cardiovasc Manag; 1999; 10(1):24-30. PubMed ID: 10350993
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of resource allocation models in selecting clinical preventive services.
    Wang LY; Haddix AC; Teutsch SM; Caldwell B
    Am J Manag Care; 1999 Apr; 5(4):445-54. PubMed ID: 10387384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACCP: economic evaluations of clinical pharmacy services: 2001-2005.
    Perez A; Doloresco F; Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT;
    Pharmacotherapy; 2009 Jan; 29(1):128. PubMed ID: 19113803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of therapeutic drug monitoring.
    Gardner DM; Hardy BG
    Can J Hosp Pharm; 1990 Feb; 43(1):7-12, xii. PubMed ID: 10113128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transparent and reproducible reports of economic evaluations of clinical pharmacy services: a goal for the future?
    Hoffman JM; Meek PD; Touchette DR; Vermeulen LC; Schumock GT
    Am J Health Syst Pharm; 2009 Mar; 66(5):442-3; author reply 443-4. PubMed ID: 19233988
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW; Pettit KG; Arnold RJ; Kaniecki DJ
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.